Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026)
Elutia (ELUT) posted Total Non-Current Liabilities of $29.3 million for Q1 2026, down 7.17% sequentially from $31.6 million in Q4 2025, and down 58.75% YoY from $71.0 million in Q1 2025.
Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
Elutia has reported Total Non-Current Liabilities for 8 years, with the latest figure at $29.3 million in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 58.75% year-over-year to $29.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.3 million (down 58.75% YoY) and the FY2025 annual result came in at $31.6 million, down 52.42% from the prior year.
- Total Non-Current Liabilities declined to $29.3 million in Q1 2026 per ELUT's latest filing, from $31.6 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $104.7 million in Q2 2024 and troughed at $29.3 million in Q1 2026.
- A 5-year average of $66.7 million and a median of $71.0 million in 2025 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities surged 101.78% in 2022, then sank 58.75% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $73.7 million in 2022, then slipped by 6.07% to $69.3 million in 2023, then fell by 4.27% to $66.3 million in 2024, then sank by 52.42% to $31.6 million in 2025, then dropped by 7.17% to $29.3 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $29.3 million, $31.6 million, and $69.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.69 Bn | 197.09 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.34 Bn | 122.87 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.44 Bn | 110.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.10 Bn | 73.56 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.73 Bn | 47.48 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 35.11 Bn | 33.16 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Elutia | 40.75 Mn | 20.85 Mn | 1.45 Mn | 24.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.29 Mn |
| Dec 31, 2025 | 31.55 Mn |
| Sep 30, 2025 | 69.30 Mn |
| Jun 30, 2025 | 66.73 Mn |
| Mar 31, 2025 | 71.02 Mn |
| Dec 31, 2024 | 66.31 Mn |
| Sep 30, 2024 | 82.40 Mn |
| Jun 30, 2024 | 104.67 Mn |
| Mar 31, 2024 | 78.00 Mn |
| Dec 31, 2023 | 69.27 Mn |
| Sep 30, 2023 | 83.62 Mn |
| Jun 30, 2023 | 74.11 Mn |
| Mar 31, 2023 | 72.60 Mn |
| Dec 31, 2022 | 73.75 Mn |
| Sep 30, 2022 | 71.62 Mn |
| Jun 30, 2022 | 53.32 Mn |
| Mar 31, 2022 | 36.85 Mn |
| Dec 31, 2021 | 52.95 Mn |
| Sep 30, 2021 | 35.49 Mn |
| Jun 30, 2021 | 38.15 Mn |